Figure 8From: Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery diseaseImmunostaining for Nε-(carboxymethyl)lysine (CML) (A) and negative control section without primary antibody (B), of left ventricular biopsy from control coronary artery bypass graft surgery patient.Back to article page